A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor.

Abroad (travel likely)RecruitingPHASE3

Conditions

Metastatic Tumor

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

BC Cancer - Centre for the North, Prince George, British Columbia, Canada
Contact: Principal Investigator (Robert Olson, MD, MSc)
BC Cancer - Vancouver, Vancouver, British Columbia, Canada
Contact: Study coordinator (Tina Zhang, MD) · srinivas.raman@bccancer.bc.ca · 604-877-6000
Contact: Principal Investigator (Srinivas Raman, MD)
London Regional Cancer Program of the Lawson Health Research Institute, London, Ontario, Canada
Contact: Study coordinator (David Palma, MD, PhD) · David.Palma@lhsc.on.ca · 519-685-8650
Contact: Principal Investigator (David Palma, MD, PhD)
Centre Hospitalier de l'Université de Montréal-CHUM, Montreal, Quebec, Canada
Contact: Study coordinator (Toni Vu) · thi_trinh_thuc.vu.med@ssss.gouv.qc.ca · 514-575-7690
Contact: Principal Investigator (Toni Vu, MD, FRCP (C)
Universitätsspital Zürich, Zurich, Switzerland
Contact: Study coordinator (Matthias Guckenberger, MD) · Matthias.Guckenberger@usz.ch · +41 44 255 35 66

View source on ClinicalTrials.gov Contact study team (email)